Episode Details

Back to Episodes

1st longer term tirzepatide study (3 years)

Episode 101 Published 1 year, 1 month ago
Description

Drs. Karl and Spencer discuss the brand new 3 year study of tirzepatide in those with prediabetes along with a discussion on semaglutide treating osteoarthritis.

Learn:

  • If people lose weight and keep it off with tirzepatide
  • How many people regain weight after stopping the medicine
  • Long-term side effects
  • If semaglutide helps with osteoarthritis

Click here to read the tirzepatide study

Click here to read the semaglutide study


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us